Exact Mass: 373.18891320000006
Exact Mass Matches: 373.18891320000006
Found 500 metabolites which its exact mass value is equals to given mass value 373.18891320000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hasubanonine
C21H27NO5 (373.18891320000006)
Endoxifen
Endoxifen (EDX) is a key active metabolite of tamoxifen (TAM) with higher affinity and specificity to estrogen receptors that also inhibits aromatase activity. (PMID: 23274567) Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia) The pharmacological activity of Tamoxifen is dependent on its conversion to its active metabolite, endoxifen, by CYP2D6. (PMID: 23711794) Tamoxifen is a largely inactive pro-drug, requiring metabolism into its most important metabolite endoxifen. Since the cytochrome P450 (CYP) 2D6 enzyme is primarily involved in this metabolism, genetic polymorphisms of this enzyme, but also drug-induced CYP2D6 inhibition can result in considerably reduced endoxifen formation and as a consequence may affect the efficacy of tamoxifen treatment. (PMID: 23760858)
alpha-Hydroxy-N-desmethyltamoxifen
alpha-Hydroxy-N-desmethyltamoxifen is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
Autumnaline
(S)-Autumnaline is an isoquinoline alkaloid. (S)-autumnaline has been reported in Colchicum autumnale, Colchicum ritchii Autumnaline is a natural organic compound classified as a protoberberine alkaloid, which is a subset of the larger category of alkaloids. It is primarily derived from plants, particularly those of the Colchicum genus, including Colchicum autumnale. This compound shares structural similarities with other alkaloids, such as colchicine, and is known for its potential biological activities. The biological functions of autumnaline are not as extensively studied as those of colchicine, but research suggests it may have several notable effects: Cytotoxic Properties: Like many alkaloids, autumnaline exhibits cytotoxicity, meaning it has the ability to damage or inhibit the growth of cells. This property could be exploited in cancer research, as cytotoxic compounds are often investigated for their potential to Inhibit tumor growth. Antioxidant Activity: Some studies have indicated that autumnaline may possess antioxidant properties. Antioxidants are important in protecting cells from damage caused by reactive oxygen species, which are implicated in various diseases and aging processes. Anti-inflammatory Effects: There is emerging evidence suggesting that certain alkaloids, including some protoberberine alkaloids, may have anti-inflammatory effects. This could be significant in the context of treating inflammatory conditions. Potential Medicinal Uses: Due to its complex structure and biological activities, autumnaline could be of interest for medicinal purposes. However, further research is needed to fully understand its potential therapeutic applications, as well as its safety and efficacy. (1S)-1,2,3,4-Tetrahydro-1-[2-(3-hydroxy-4,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-7-isoquinolinol. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=23068-65-7 (retrieved 2024-10-11) (CAS RN: 23068-65-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Spirotetramat
C21H27NO5 (373.18891320000006)
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 686; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9268; ORIGINAL_PRECURSOR_SCAN_NO 9267 CONFIDENCE standard compound; INTERNAL_ID 686; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9334; ORIGINAL_PRECURSOR_SCAN_NO 9333 CONFIDENCE standard compound; INTERNAL_ID 686; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9232; ORIGINAL_PRECURSOR_SCAN_NO 9231 CONFIDENCE standard compound; INTERNAL_ID 686; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9326; ORIGINAL_PRECURSOR_SCAN_NO 9325 CONFIDENCE standard compound; INTERNAL_ID 686; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9276; ORIGINAL_PRECURSOR_SCAN_NO 9275 CONFIDENCE standard compound; INTERNAL_ID 686; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9319; ORIGINAL_PRECURSOR_SCAN_NO 9318
N-Jasmonoyltyrosine
C21H27NO5 (373.18891320000006)
N-Jasmonoyltyrosine is found in pulses. N-Jasmonoyltyrosine is a constituent of the flowers of Vicia faba. Constituent of the flowers of Vicia faba. N-Jasmonoyltyrosine is found in pulses.
alpha-Hydroxy-N-desmethyl-tamoxifen
alpha-Hydroxy-N-desmethyl-tamoxifen is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone
(2,3-Dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol
C22H28FNO3 (373.20531100000005)
2-Hydroxy-3-methoxy-6beta-naltrexol
C21H27NO5 (373.18891320000006)
Bunazosin
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
4-(2-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-phenylethyl)pyridine
Clebopride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
Motesanib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
N-Desmethyltrimebutine
C21H27NO5 (373.18891320000006)
(2s,5s)-2-Methyl-5-(4-(5-methyl-2-(p-tolyl)oxazol-4-yl)butyl)-1,3-dioxane-2-carboxylic acid
C21H27NO5 (373.18891320000006)
p-Chlorodisopyramide
C21H28ClN3O (373.19207880000005)
Ritobegron
C21H27NO5 (373.18891320000006)
3-epi-2,18-Dimethoxyschelhammericine
C21H27NO5 (373.18891320000006)
Equisetin
C22H31NO4 (373.22529660000004)
A member of the class of tetramic acids that is trichosetin in which the hydrogen attached to the lactam nitrogen has been replaced by a methyl group. It is produced by the filamentous fungus Fusarium heterosporum.
(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone
2-acetoxyisotaxodine|O2-Ac-2-Hydroxyisotaxodine
C21H27NO5 (373.18891320000006)
(6alpha,7alpha)-6-hydroxy-21-(2-hydroxyethyl)-4-methyl-7,20-epoxyatid-16-en-19-one|spiramilactam A
C22H31NO4 (373.22529660000004)
pyrrole-2-carboxylic acid 13-hydroxy-11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester
C20H27N3O4 (373.20014620000006)
6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinoline
C21H27NO5 (373.18891320000006)
2,3-methanediyldioxy-4,6beta-dimethoxy-17-methyl-10a-homo-morphin-8(14)-en-7beta-ol|Alkaloid CC-2|alkaloid CC-2 (Colchicum cornigerum)
C21H27NO5 (373.18891320000006)
(2Z)-5-{[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]amino}-2-pentenyl 3-methylbutanoate
C21H27NO3S (373.17115520000004)
ent-4,5alpha-epoxy-2,3,6beta-trimethoxy-17-methyl-10a-homo-morphin-8(14)-en-7beta-ol|Kreysiginin|Kreysiginine
C21H27NO5 (373.18891320000006)
3-oxo-11alpha,19,22-trihydroxycona-1,4-diene|pubatriol
C22H31NO4 (373.22529660000004)
calpurmeninepyrrolecarboxylic acid
C20H27N3O4 (373.20014620000006)
(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-yliden)-amin|(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-yliden)-amine|1,5,5-trimethyl-2,2-diphenyl-1,2,2,4-tetrahydro-4,4-azanylylidene-bis-pyrazol-3-one|Methylrubazonsaeure
(3-Oxo-2-pentylcyclopentyl) acetic acid
C18H23N5O4 (373.17499580000003)
Zoolobelin
C22H28ClNO2 (373.18084580000004)
Lobeline (α-Lobeline) hydrochloride is a brain-penetrant nicotinic receptor agonist. Lobeline hydrochloride increases dopamine (DA) release by inhibiting DA uptake into synaptic vesicles, and altering presynaptic DA storage. Lobeline hydrochloride is effective in smoking cessation[1][2]. Lobeline hydrochloride, a nicotinic receptor agonist, acting as a potent antagonist at both α3β2 and α4β2 neuronal nicotinic receptor subtypes.
C22H31NO4_(5R)-3-({(1S,2R,4aS,6R,8aR)-1,6-Dimethyl-2-[(1E)-1-propen-1-yl]-1,2,4a,5,6,7,8,8a-octahydro-1-naphthalenyl}carbonyl)-4-hydroxy-5-(hydroxymethyl)-1-methyl-1,5-dihydro-2H-pyrrol-2-one
C22H31NO4 (373.22529660000004)
Volinanserin
C22H28FNO3 (373.20531100000005)
CONFIDENCE standard compound; INTERNAL_ID 893; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7066; ORIGINAL_PRECURSOR_SCAN_NO 7062 D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist CONFIDENCE standard compound; INTERNAL_ID 893; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7133; ORIGINAL_PRECURSOR_SCAN_NO 7131 CONFIDENCE standard compound; INTERNAL_ID 893; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7168; ORIGINAL_PRECURSOR_SCAN_NO 7167 CONFIDENCE standard compound; INTERNAL_ID 893; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7181; ORIGINAL_PRECURSOR_SCAN_NO 7180 CONFIDENCE standard compound; INTERNAL_ID 893; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7111; ORIGINAL_PRECURSOR_SCAN_NO 7109 CONFIDENCE standard compound; INTERNAL_ID 893; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7184; ORIGINAL_PRECURSOR_SCAN_NO 7181 Volinanserin is a potent and selective antagonist of 5-HT2 receptor, with a Ki of 0.36 nM, and shows 300-fold selectivity for 5-HT2 receptor over 5-HT1c, alpha-1 and DA D2 receptors. Volinanserin has antipsychotic activity.
Ala Ala Gly Arg
Ala Ala Asn Val
Ala Ala Arg Gly
Ala Ala Val Asn
Ala Gly Ala Arg
Ala Gly Ile Asn
Ala Gly Leu Asn
Ala Gly Asn Ile
Ala Gly Asn Leu
Ala Gly Gln Val
Ala Gly Arg Ala
Ala Gly Val Gln
Ala Ile Gly Asn
Ala Ile Asn Gly
Ala Leu Gly Asn
Ala Leu Asn Gly
Ala Asn Ala Val
Ala Asn Gly Ile
Ala Asn Gly Leu
Ala Asn Ile Gly
Ala Asn Leu Gly
Ala Asn Val Ala
Ala Gln Gly Val
Ala Gln Val Gly
Ala Arg Ala Gly
Ala Arg Gly Ala
Ala Val Ala Asn
Ala Val Gly Gln
Ala Val Asn Ala
Ala Val Gln Gly
Bunazosin
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Gly Ala Ala Arg
Gly Ala Ile Asn
Gly Ala Leu Asn
Gly Ala Asn Ile
Gly Ala Asn Leu
Gly Ala Gln Val
Gly Ala Arg Ala
Gly Ala Val Gln
Gly Gly Ile Gln
Gly Gly Leu Gln
Gly Gly Gln Ile
Gly Gly Gln Leu
Gly Ile Ala Asn
Gly Ile Gly Gln
Gly Ile Asn Ala
Gly Ile Gln Gly
Gly Leu Ala Asn
Gly Leu Gly Gln
Gly Leu Asn Ala
Gly Leu Gln Gly
Gly Asn Ala Ile
Gly Asn Ala Leu
Gly Asn Ile Ala
Gly Asn Leu Ala
Gly Asn Pro Ser
Gly Asn Ser Pro
Gly Pro Asn Ser
Gly Pro Ser Asn
Gly Gln Ala Val
Gly Gln Gly Ile
Gly Gln Gly Leu
Gly Gln Ile Gly
Gly Gln Leu Gly
Gly Gln Val Ala
Gly Arg Ala Ala
Gly Ser Asn Pro
Gly Ser Pro Asn
Gly Val Ala Gln
Gly Val Gln Ala
Ile Ala Gly Asn
Ile Ala Asn Gly
Ile Gly Ala Asn
Ile Gly Gly Gln
Ile Gly Asn Ala
Ile Gly Gln Gly
Ile Asn Ala Gly
Ile Asn Gly Ala
Ile Gln Gly Gly
Leu Ala Gly Asn
Leu Ala Asn Gly
Leu Gly Ala Asn
Leu Gly Gly Gln
Leu Gly Asn Ala
Leu Gly Gln Gly
Leu Asn Ala Gly
Leu Asn Gly Ala
Leu Gln Gly Gly
Asn Ala Ala Val
Asn Ala Gly Ile
Asn Ala Gly Leu
Asn Ala Ile Gly
Asn Ala Leu Gly
Asn Ala Val Ala
Asn Gly Ala Ile
Asn Gly Ala Leu
Asn Gly Ile Ala
Asn Gly Leu Ala
Asn Gly Pro Ser
Asn Gly Ser Pro
Asn Ile Ala Gly
Asn Ile Gly Ala
Asn Leu Ala Gly
Asn Leu Gly Ala
Asn Pro Gly Ser
Asn Pro Ser Gly
Asn Ser Gly Pro
Asn Ser Pro Gly
Asn Val Ala Ala
Pro Gly Asn Ser
Pro Gly Ser Asn
Pro Asn Gly Ser
Pro Asn Ser Gly
Pro Ser Gly Asn
Pro Ser Asn Gly
Gln Ala Gly Val
Gln Ala Val Gly
Gln Gly Ala Val
Gln Gly Gly Ile
Gln Gly Gly Leu
Gln Gly Ile Gly
Gln Gly Leu Gly
Gln Gly Val Ala
Gln Ile Gly Gly
Gln Leu Gly Gly
Gln Val Ala Gly
Gln Val Gly Ala
Arg Ala Ala Gly
Arg Ala Gly Ala
Arg Gly Ala Ala
Ser Gly Asn Pro
Ser Gly Pro Asn
Ser Asn Gly Pro
Ser Asn Pro Gly
Ser Pro Gly Asn
Ser Pro Asn Gly
Val Ala Ala Asn
Val Ala Gly Gln
Val Ala Asn Ala
Val Ala Gln Gly
Val Gly Ala Gln
Val Gly Gln Ala
Val Asn Ala Ala
Val Gln Ala Gly
Val Gln Gly Ala
Clebopride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
N-Jasmonoyltyrosine
C21H27NO5 (373.18891320000006)
N-jasmonoyl-L-tyrosine
C21H27NO5 (373.18891320000006)
2-FLUORO-4-[[4-(TRANS-4-PENTYLCYCLOHEXYL)PHENYL]ETHYNYL]CYANOPHENYL
1,1-DIPHENYL-3-(PIPERIDIN-1-YL)PROPYL METHANESULFONATE
C21H27NO3S (373.17115520000004)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(3-cyanophenyl)-N-cyclopentyl- (9CI)
3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1H-indol-2-one
C24H23NO3 (373.16778480000005)
Sepimostat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Sepimostat (FUT-187 free base) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat inhibits the Ifenprodil binding with a Ki value of 27.7?μM[1].
3-N-BOC-AMINO-1-[2-AMINO-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHYL]-PYRROLIDINE
N N-BIS((R)-(+)-1-PHENYLETHYL)PHTHALAMI&
C24H23NO3 (373.16778480000005)
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(4-cyanophenyl)-N-cyclopentyl- (9CI)
amineptine hydrochloride
C22H28ClNO2 (373.18084580000004)
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
N-(5-CHLORO-3-((4-(DIETHYLAMINO)-2-METHYLPHENYL)IMINO)-4-METHYL-6-OXOCYCLOHEXA-1,4-DIEN-1-YL)ACETAMIDE
Urea, N-[2-[(3-cyano-6,8-dimethyl-2-quinolinyl)amino]ethyl]-N-(phenylmethyl)- (9CI)
N-(3,4,6-TRI-O-ACETYL-β-D-GLUCOPYRANOSYL) PIPERIDINE
2-[2-[4-(1H-Indol-3-yl)-1-piperidinyl]ethyl]-1H-isoindole-1,3(2H)-dione
N-tert-Butyl-O-[1-[4-(chloromethyl)phenyl]ethyl]-N-(2-Methyl-1-phenylpropyl)hydroxylamine
(3-BOC-AMINO-AZETIDIN-1-YL)-NAPHTHALEN-2-YL-ACETICACID
C20H27N3O4 (373.20014620000006)
1-BOC-4-[CARBOXY-(1H-INDOL-2-YL)-METHYL]-[1,4]DIAZEPANE
C20H27N3O4 (373.20014620000006)
2-amino-1-[3-(hydroxymethyl)cyclobutyl]-4-(3-phenylmethoxyphenyl)pyrrole-3-carbonitrile
5-ISOPROPYL-1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)-1H-1,2,3-TRIAZOL-4-OL
C19H28BN3O4 (373.21727580000004)
Benzyl 4-(4-(2,3-dihydroxypropoxy)-phenyl)butylcarbamate
C21H27NO5 (373.18891320000006)
(4-BENZOYL-PHENYL)-PHOSPHONICACIDDIETHYLESTER
C20H27N3O4 (373.20014620000006)
tert-Butyl 2-(2-(3-(trifluoromethyl)phenoxy)ethyl)piperidine-1-carboxylate
C19H26F3NO3 (373.18646820000004)
1-[(E)-(Dimethylamino)methylene]-3-tritylthiourea
C23H23N3S (373.16125980000004)
tert-Butyl 5-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
C20H28BNO5 (373.20604280000003)
tert-butyl 4-[2-amino-1-[4-(trifluoromethyl)phenyl]ethyl]piperazine-1-carboxylate
1H-Benzimidazole,2-[1-[[1-(phenylmethyl)-1H-tetrazol-5-yl]methyl]-4-piperidinyl]-(9CI)
S1RA hydrochloride
S1RA (E-52862) hydrochloride is an orally active and selective sigma-1 receptor (σ1R) antagonist with a Ki value of 17 nM. S1RA hydrochloride shows good selectivity against σ2R (Ki >1000 nM). S1RA hydrochloride is a human 5-HT2B receptor antagonist with an IC50 value of 4.7 μM. S1RA hydrochloride inhibits neuropathic pain and activity-induced spinal sensitization[1][2].
N,N-BIS((S)-1-PHENYLETHYL) PHTHALAMIC ACID
C24H23NO3 (373.16778480000005)
tert-Butyl 7-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
C20H28BNO5 (373.20604280000003)
tert-Butyl 6-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
C20H28BNO5 (373.20604280000003)
(4s)-(-)-4,5-dihydro-2-[2-(diphenylphosphino)phenyl]-4-isopropyloxazole
(R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline
disodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate
TERT-BUTYL 5-(6-HYDROXYNAPHTHALEN-2-YL)-2,2-DIMETHYL-1,3-DIOXAN-5-YLCARBAMATE
C21H27NO5 (373.18891320000006)
Ritobegron
C21H27NO5 (373.18891320000006)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
2-methyl-5-[4-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]butyl]-1,3-dioxane-2-carboxylic Acid
C21H27NO5 (373.18891320000006)
5-(3-((1-amino-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl)-1H-indol-1-yl)pentanoicacid
C20H27N3O4 (373.20014620000006)
[1-acetyl-3,6-bis(tert-butylsulfanyl)-4-methyl-3,6-dihydro-2H-pyridin-2-yl] acetate
6-[(Z)-Amino(imino)methyl]-N-[3-(cyclopentyloxy)phenyl]-2-naphthamide
(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
N-{(3s,4s)-4-[(6-Amino-4-Methylpyridin-2-Yl)methyl]pyrrolidin-3-Yl}-N-(4-Chlorobenzyl)ethane-1,2-Diamine
C20H28ClN5 (373.20331180000005)
N-{(3r,4s)-4-[(6-Amino-4-Methylpyridin-2-Yl)methyl]pyrrolidin-3-Yl}-N-(3-Chlorobenzyl)ethane-1,2-Diamine
C20H28ClN5 (373.20331180000005)
Lobeline hydrochloride
C22H28ClNO2 (373.18084580000004)
Lobeline (α-Lobeline) hydrochloride is a brain-penetrant nicotinic receptor agonist. Lobeline hydrochloride increases dopamine (DA) release by inhibiting DA uptake into synaptic vesicles, and altering presynaptic DA storage. Lobeline hydrochloride is effective in smoking cessation[1][2]. Lobeline hydrochloride, a nicotinic receptor agonist, acting as a potent antagonist at both α3β2 and α4β2 neuronal nicotinic receptor subtypes.
Motesanib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
3-(3,4-Dimethoxyphenyl)-6-(3-propan-2-ylphenyl)-[1,2,4]triazolo[4,3-a]pyridine
4-(2-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-phenylethyl)pyridine
(10S,12R)-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.02,10.04,9.015,20]henicosa-4,6,8,15,17,19-hexaene-13,21-dione
(2R,4E)-2-amino-5-({[(2S,3R)-2-hydroxy-3-(1H-indol-3-yl)butanamido]methanimidoyl}amino)pent-4-enoate
C18H23N5O4 (373.17499580000003)
(E,2S)-2-amino-5-[[amino-[[(2S,3R)-2-hydroxy-3-(1H-indol-3-yl)butanoyl]amino]methylidene]amino]pent-4-enoic acid
C18H23N5O4 (373.17499580000003)
(2S)-2-[[2-[(1R,2S)-2-[(Z)-5-hydroxypent-2-enyl]-3-oxocyclopentyl]acetyl]amino]-3-phenylpropanoic acid
C21H27NO5 (373.18891320000006)
Survector
C22H28ClNO2 (373.18084580000004)
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
1-[Tert-butyl-[(3,5-dimethylphenyl)-oxomethyl]amino]-3-(4-chlorophenyl)urea
N-[(2-hydroxy-1-naphthalenyl)-(4-methylphenyl)methyl]cyclohexanecarboxamide
8-oxoresolvin D1(1-)
A polyunsaturated fatty acid anion that is the conjugate base of 8-oxoresolvin D1, obtained by deprotonation of the carboxy group; major species at pH 7.3.
17-oxoresolvin D1(1-)
A polyunsaturated fatty acid that is the conjugate base of 17-oxoresolvin D1, obtained by deprotonation of the carboxy group; major species at pH 7.3.
10-Methyl-3-(2-phenylethyl)-2-propan-2-ylpyrimido[4,5-b]quinoline-4,5-dione
(3aR)-10,10-dimethyl-2-(4-methylbenzyl)-4,9-dihydro-3aH-imidazo[1,5-b]-carboline-1,3-quinone
5-[1-[(3,5-Dimethoxyphenyl)methylamino]propylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione
C19H23N3O5 (373.16376280000003)
N-[2-(4-methoxyphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline
C19H23N3O5 (373.16376280000003)
2-Phenylbutanoic acid [2-oxo-2-(2-phenylanilino)ethyl] ester
C24H23NO3 (373.16778480000005)
1-(4-chlorophenyl)-N-(2-furanylmethyl)-N-[[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]methanamine
(15S)-10,10-Dimethyl-13-[(4-methylphenyl)methyl]-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
(15R)-10,10-Dimethyl-13-[(3-methylphenyl)methyl]-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
(15S)-10,10-Dimethyl-13-[(3-methylphenyl)methyl]-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
(15S)-10,10-Dimethyl-13-[(2-methylphenyl)methyl]-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
(15R)-10,10-Dimethyl-13-[(2-methylphenyl)methyl]-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
(4E,8E)-10-(4,6-dihydroxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate
4-[2-[[1-(2-Oxolanylmethyl)-5-phenyl-2-imidazolyl]thio]ethyl]morpholine
C20H27N3O2S (373.18238820000005)
2-[[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]-1,3-thiazole
C23H23N3S (373.16125980000004)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-2-(piperidine-1-carbonyl)-1-propanoyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C20H27N3O4 (373.20014620000006)
(4-fluorophenyl)-[(1R,5S)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile
(2S,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-1-(1-oxopropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C20H27N3O4 (373.20014620000006)
(3Z)-3-[(E)-1-Hydroxy-2,4-dimethyloct-6-enylidene]-5-[hydroxy-(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione
C21H27NO5 (373.18891320000006)
13-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotridecanoate
(12R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotridecanoate
2-[(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)diazenyl]-3-(2-methylphenyl)-3-oxopropanenitrile
(3Z,5R)-3-[[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(E)-prop-1-enyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
C22H31NO4 (373.22529660000004)
(1S,7R,8S,13R,16S)-11-ethyl-7,16-dihydroxy-13-methyl-6-methylidene-11-oxido-11-azoniahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecan-4-one
C22H31NO4 (373.22529660000004)
(1S,7R,8S,13R,16S,17R)-11-ethyl-7,16-dihydroxy-13-methyl-6-methylidene-11-oxido-11-azoniahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecan-4-one
C22H31NO4 (373.22529660000004)
2-[[2-[(4-Amino-4-carboxybutanoyl)amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid
(1S,2R,7R,8S,13R,16S,17R)-11-ethyl-7,16-dihydroxy-13-methyl-6-methylidene-11-oxido-11-azoniahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecan-4-one
C22H31NO4 (373.22529660000004)
(2S)-N-(5-aminopentyl)-2-[[2-(1H-indol-3-yl)acetyl]amino]butanediamide
7-oxoresolvin D2(1-)
A docosanoid anion that is the conjugate base of 7-oxoresolvin D2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
16-oxoresolvin D2(1-)
A docosanoid anion that is the conjugate base of 16-oxoresolvin D2, obtained by deprotonation of the carboxy group; major species at pH 7.3.
[1-(5-Fluoropentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone
NADPH oxidase-IN-1
C20H27N3O2S (373.18238820000005)
NADPH oxidase-IN-1 is an orally active NADPH oxidase (Nox) inhibitor, related with neuronal inflammation. NADPH oxidase-IN-1 can cross the blood-brain barrier (BBB), inhibits Nox2 and Nox4 with IC50s of 1.9 μM and 2.47 μM, respectively. NADPH oxidase-IN-1 suppresses pro-inflammatory cytokines production and LPS-mediated microglial migration, also has in vivo efficacy[1].
5-hydroxy-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-16-yl acetate
C21H27NO5 (373.18891320000006)
8,11-dihydroxy-7-(hydroxymethyl)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one
C22H31NO4 (373.22529660000004)
4-hydroxy-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-16-yl acetate
C21H27NO5 (373.18891320000006)
(1r,9s,10s)-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one
C21H27NO5 (373.18891320000006)
(3e,5s)-3-{[(1r,2r,4ar,6r,8ar)-1,6-dimethyl-2-[(1e)-prop-1-en-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl](hydroxy)methylidene}-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
C22H31NO4 (373.22529660000004)
(3s,6s,11ar)-1,4-dihydroxy-3-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-7-one
C20H27N3O4 (373.20014620000006)
(1s,2r,4s,9s,10r)-3-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
(1s,9r,10r)-4,5,11,12-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
(2s,4e)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2s,4s,6z)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
4,5,11,12-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
(1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl (3s)-3-hydroxybutanoate
C21H27NO5 (373.18891320000006)
(2r,10s,12s)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
16-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
4,5,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
(1r,2s,4s,9r,10r,12s)-12-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-2,4-dimethyloct-6-en-1-ylidene)-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
(3s,10s,14r,15s,17r,18s)-15-hydroxy-14,18-dimethyl-6-oxa-12-azapentacyclo[13.4.1.1³,¹⁹.0¹⁰,¹⁸.0¹²,¹⁷]henicos-1(19)-ene-2,7,20-trione
C21H27NO5 (373.18891320000006)
(2-{2-[2-(3,4-dimethoxyphenyl)ethyl]-4,5-dimethoxyphenyl}ethyl)dimethylamine
C22H31NO4 (373.22529660000004)
(1'r,3s,3's,7's,12's)-1,4',4',12',14'-pentamethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,10',13'-tetrone
C20H27N3O4 (373.20014620000006)
(1s,16r,17r)-5-hydroxy-4,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-16-yl acetate
C21H27NO5 (373.18891320000006)
(10s,12s)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
(3r)-3-{[(2s,3r)-2-{[(2e,4e)-1-hydroxy-4-methylhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoyl]oxy}butanoic acid
C21H27NO5 (373.18891320000006)
(1s,19s,20r)-9,19,20-trimethoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraene
C21H27NO5 (373.18891320000006)
(1r,2r,3s,4s,9r,10s)-3-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
(2r,4e)-5-hydroxy-2-[(r)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2s,4s)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
2-({1-hydroxy-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)-3-(4-hydroxyphenyl)propanoic acid
C21H27NO5 (373.18891320000006)
(2r)-5-hydroxy-2-[(r)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2s,4s)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
(1r,2s,4r,9s,10r,16s)-16-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
(1r,3r,4r,10s,14s,15r,18r,19s)-19-hydroxy-18-(hydroxymethyl)-14-methyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icos-7(20)-ene-3-carboxylic acid
C22H31NO4 (373.22529660000004)
3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
(1s,16r,17r)-4-hydroxy-5,17-dimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraen-16-yl acetate
C21H27NO5 (373.18891320000006)
(10s,12r)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
3-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
19-hydroxy-18-(hydroxymethyl)-14-methyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icos-7(20)-ene-3-carboxylic acid
C22H31NO4 (373.22529660000004)
(1's,3r,3'r,7'r,12'r)-1,4',4',12',14'-pentamethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,10',13'-tetrone
C20H27N3O4 (373.20014620000006)
(1r,4r)-1-[(2s)-butan-2-yl]-3-hydroxy-4-isopropyl-1,8-dimethoxy-4h-pyrazino[2,1-b]quinazolin-6-one
C20H27N3O4 (373.20014620000006)
(2s)-2-[(1-hydroxy-2-{3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl}ethylidene)amino]-3-(4-hydroxyphenyl)propanoic acid
C21H27NO5 (373.18891320000006)
(2s)-2-({1-hydroxy-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethylidene}amino)-3-(4-hydroxyphenyl)propanoic acid
C21H27NO5 (373.18891320000006)
(1r,9s,10s)-4,5,11,12-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
7-(4,5-dimethoxy-7-methylnaphthalen-1-yl)-1,3-dimethylisoquinolin-8-ol
C24H23NO3 (373.16778480000005)
(1s,2s,4s,9s,10r,12s)-12-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
(1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl (3r)-3-hydroxybutanoate
C21H27NO5 (373.18891320000006)
(2r,3r)-3-{[(1s)-1-{[(5s)-5-amino-5-carboxypentyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl 3-hydroxybutanoate
C21H27NO5 (373.18891320000006)
(2s,10r,12r)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
(2s)-2-({1-hydroxy-2-[(1r,2r)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethylidene}amino)-3-(4-hydroxyphenyl)propanoic acid
C21H27NO5 (373.18891320000006)
(2e,4e,6e)-n-[(3z)-5-[(3-methylbutanoyl)oxy]pent-3-en-1-yl]-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid
C21H27NO3S (373.17115520000004)
5,9,10-trimethoxy-16-methyl-7-oxa-16-azapentacyclo[10.6.1.0¹,⁶.0²,¹⁵.0⁸,¹⁹]nonadeca-2,8,10,12(19)-tetraen-4-ol
C21H27NO5 (373.18891320000006)
(1r,4s,5s,6s,15r)-5,9,10-trimethoxy-16-methyl-7-oxa-16-azapentacyclo[10.6.1.0¹,⁶.0²,¹⁵.0⁸,¹⁹]nonadeca-2,8,10,12(19)-tetraen-4-ol
C21H27NO5 (373.18891320000006)
4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one
C21H27NO5 (373.18891320000006)
(1s,9r,10s)-4,5,11,12-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-1,3-dimethylisoquinolin-8-ol
C24H23NO3 (373.16778480000005)
(1r,3r,5s,6r,7s)-6-hydroxy-8-methyl-7-(1h-pyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate
C19H23N3O5 (373.16376280000003)
(1r,9s,10r)-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,12-tetraen-11-one
C21H27NO5 (373.18891320000006)
(1r,4s,5s,6s,15s)-5,9,10-trimethoxy-16-methyl-7-oxa-16-azapentacyclo[10.6.1.0¹,⁶.0²,¹⁵.0⁸,¹⁹]nonadeca-2,8,10,12(19)-tetraen-4-ol
C21H27NO5 (373.18891320000006)
(2s,4e)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2s,4s)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
(1r)-1-[2-(3-hydroxy-4,5-dimethoxyphenyl)ethyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol
C21H27NO5 (373.18891320000006)
13-hydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
(2r,4e)-5-hydroxy-2-[(r)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2s,4s,6z)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
(1r,9s,10r)-4,5,11,12-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one
C21H27NO5 (373.18891320000006)
3-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3h-1,4-benzodiazepine-2,5-diol
(2r)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2s,4s)-1-hydroxy-2,4-dimethyloct-6-en-1-ylidene]-2h-pyrrol-3-one
C21H27NO5 (373.18891320000006)
9,19,20-trimethoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraene
C21H27NO5 (373.18891320000006)
1,4',4',12',14'-pentamethyl-9',14'-diazaspiro[pyrrolidine-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecane]-2,5,10',13'-tetrone
C20H27N3O4 (373.20014620000006)
(1s,2r,3s,4s,9s,10r)-3-hydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 1h-pyrrole-2-carboxylate
C20H27N3O4 (373.20014620000006)
(2r,3r)-3-{[(2s,3r)-2-{[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoyl]oxy}-2-methylbutanoic acid
C21H27NO5 (373.18891320000006)